Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 743 of 1,261

  1. US 9085598

    Compounds targeting the cell invasion protein complex, their pharmaceutical compositions and methods of use thereof

    OCEAN UNIVERSITY OF CHINA · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  2. US 9085644

    Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

    The Regents of the University of California · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  3. US 9084808

    Modified small interfering RNA molecules and methods of use

    Arrowhead Research Corporation · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  4. US 9085578

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  5. US 9084830

    Microvesicles derived from cell protoplast and use thereof

    Aeon Medix Inc. · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  6. US 9084820

    Magnetic microstructures for magnetic resonance imaging

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  7. US 9084819

    Magnetic microstructures for magnetic resonance imaging

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  8. US 9084809

    Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni

    United States of America as represented by the Secretary of the Air Force · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  9. US 9084773

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  10. US 9084782

    Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis

    The Regents of the University of California · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  11. US 9084795

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  12. US 9084762

    T-cell immunogens derived from anti-viral proteins and methods of using same

    The Regents of the University of California · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  13. US 9085599

    2′allene-substituted nucleoside derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  14. US 9084761

    Use of interleukin-15 to treat cardiovascular diseases

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  15. US 9084746

    Therapeutic applications of SMAD7

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  16. US 9084828

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  17. US 9085577

    7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  18. WO 2015104417

    UTILISATION DU CABAZITAXEL POUR LE TRAITEMENT DE L'ADÉNOCARCINOME GASTRIQUE

    AVENTIS PHARMA SA [FR] · Granted Jul 16, 2015 · Expires Jul 11, 2035

    granted

  19. US 9079865

    Hydrazide containing nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  20. US 9079944

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  21. US 9079898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  22. US 9078905

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  23. US 9079948

    Human antibodies to Fel d1 and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  24. US 9079974

    GH-RH analogs with potent agonistic effects

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.